US2016115438A1PendingUtilityA1
Integrated Continuous Isolation of Fluid Streams From Sterile Process Vessels
Est. expiryOct 24, 2034(~8.3 yrs left)· nominal 20-yr term from priority
Inventors:Robert Snow
C12M 1/12C12M 1/26C12M 29/04C12M 29/26C12P 21/00C12M 37/00C12M 37/06C12M 29/10C12M 33/04C12M 37/02C12M 23/58C12M 1/00
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided herein are isolation processes and the associated hardware to allow fluid streams to be isolated from a sterilized system (e.g., a sterile process vessel) that contains a sterile process. The isolation processes described herein allow for continuous removal of fluid streams (e.g., waste streams, liquid containing recombinant therapeutic proteins) from a sterilized system (e.g., a biological manufacturing system), which provides for less manual manipulation of the sterilized system and a decreased risk of contaminating the sterilized system.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of inhibiting contamination of a sterilized system, the method comprising
providing a system comprising first vessel, wherein the first vessel comprises a liquid; flowing a first volume of the liquid out of the first vessel and through a volume of sterilizing gas and into a second vessel.
2 . The method of claim 1 , wherein the volume of sterilizing gas is disposed within a headspace of the second vessel.
3 . The method of claim 2 , wherein the second vessel comprises
(i) a fluid inlet configured such that the volume of liquid entering the second vessel passes through the head space, (ii) a fluid outlet configured such that liquid exiting the second vessel is flowed from below the sterilizing gas-filled headspace, (iii) at least one gas inlet; and (iv) at least one gas outlet, wherein the fluid inlet is in fluid communication with the first vessel.
4 . The method of claim 3 , wherein the first vessel comprises
a fluid outlet in fluid communication with a fluid inlet of the second vessel.
5 . The method of claim 1 , wherein during the process the second vessel is at least partially filled with a liquid.
6 . The method of claim 2 , wherein the sterilizing gas is sparged into the second vessel or introduced directly into the head space of the second vessel.
7 . The method of claim 1 , wherein the first vessel is a sterilized vessel.
8 . The method of claim 1 , wherein the sterilized system is a biological manufacturing system or a pharmaceutical manufacturing system.
9 . The method of claim 8 , wherein the first vessel is a bioreactor, a chromatography system, a microfiltration (MF) system, or an ultrafiltration/diafiltration (UF/DF) system.
10 . The method of claim 1 , wherein the liquid in the first vessel comprises a cell comprising a therapeutic protein.
11 . The method of claim 1 , wherein the liquid in the first vessel comprises a recombinant therapeutic protein.
12 . The method of claim 11 , wherein the recombinant protein is secreted from a cell or is not secreted from a cell.
13 . The method of claim 1 , wherein the first volume of the liquid comprises a recombinant therapeutic protein.
14 . The method of claim 1 , wherein the liquid in the first vessel does not comprise a recombinant therapeutic protein.
15 . The method of claim 1 , wherein the first volume does not comprise a recombinant therapeutic protein.
16 . The method of claim 1 , wherein the liquid in the first vessel comprises fermentation by-products.
17 . The method of claim 13 , further comprising:
(i) flowing a second volume of liquid from the second vessel into a first multi-column chromatography system (MCCS1); (ii) capturing said recombinant therapeutic protein in the liquid culture medium using the MCCS1, wherein the eluate of the MCCS1 containing the recombinant therapeutic protein is continuously fed into a second multi-column chromatography system (MCCS2); and (iii) purifying and polishing the recombinant therapeutic protein using the MCCS2, wherein the eluate from the MCCS2 is a recombinant therapeutic protein; and wherein the process is integrated and runs continuously from said first vessel to the eluate from the MCCS2 that is the recombinant therapeutic protein.
18 . The method of claim 13 , further comprising flowing a second volume of liquid from the second vessel into an apparatus for purifying and polishing the recombinant protein.
19 . The method of claim 17 , wherein the second volume of liquid comprises a recombinant protein.
20 . The method of claim 11 , wherein the recombinant therapeutic protein is an antibody or antibody fragment, an enzyme, an engineered protein, or an immunogenic protein or protein fragment.
21 . The method of claim 1 , wherein the sterilizing gas is selected from the group consisting of ozone, ethylene oxide, nitrogen dioxide, or vaporized hydrogen peroxide.
22 . The method of claim 1 , wherein the first volume of liquid is a waste stream.
23 . A system for isolating sterile process streams from non-sterile environments, comprising:
a first vessel comprising a fluid outlet; and at least one second vessel comprising: (i) a fluid inlet in fluid communication with the fluid outlet of the first vessel and configured such that fluid entering the second vessel passes through a sterilizing-gas filled head space within the second vessel, (ii) a fluid outlet configured such that fluid exiting second vessel is removed from below the sterilizing gas-filled headspace within the second vessel, (iii) at least one gas inlet; and (iv) at least one gas outlet.
24 . The system of claim 23 , wherein the first vessel is a component of a biological manufacturing system.
25 . The system of claim 24 , wherein the first vessel is a fluid conduit, a bioreactor, chromatography system, a microfiltration (MF) system, or a ultrafiltration/diafiltration (UF/DF) system.
26 . The system of claim 25 , wherein the bioreactor is a production bioreactor or a seed bioreactor.
27 . The system of claim 25 , wherein the bioreactor is a perfusion bioreactor or a batch-fed bioreactor.
28 . The system of claim 23 , further comprising a fluid conduit disposed between the first vessel and the second vessel.
29 . The system of claim 28 , further comprising a filter disposed in the fluid conduit between the first vessel and the second vessel and configured to remove particulate matter from the fluid in the fluid conduit.
30 . The system of claim 28 , further comprising a pump system disposed in the fluid conduit.
31 . The system of claim 30 , wherein the pump system comprises a pump configured to remove a volume of fluid from the vessel outlet and flow the volume into the fluid inlet of the second vessel.
32 . The system of claim 23 , further comprising a pump system in fluid communication with the fluid outlet of the second vessel.
33 . The system of claim 31 , further comprising a filter disposed in the fluid conduit between the first vessel and the pump, and configured to remove particulate matter from the fluid present in the fluid conduit.
34 . The system of claim 23 , wherein the first vessel and the second vessel are disposed on a skid.
35 . The system of claim 23 , wherein the sterilizing gas is selected from the group consisting of ozone, ethylene oxide, nitrogen dioxide, or vaporized hydrogen peroxide.
36 . The system of claim 23 , wherein at least one gas outlet is configured to continuously or periodically vent gas from the second vessel.
37 . The system of claim 23 , wherein at least one gas outlet is in gas communication with an ozone destruction unit.
38 . The system of claim 23 , wherein at least one gas inlet is in gas communication with a system for generating or delivering a sterilizing gas, or for generating and delivering a sterilizing gas.
39 . The system of claim 38 , wherein the system for generating or delivering a sterilizing gas is an ozone generation or delivery system, or an ozone generation and delivery system.
40 . The system of claim 23 , wherein at least one gas inlet is connected to one or more gas sparging elements which permit gas to be emitted into the second vessel.
41 . The system of claim 40 , wherein the gas sparging element is a filter, an open pipe or a frit.
42 . The system of claim 23 , further comprising a dissolved gas probe.
43 . The system of claim 23 , further comprising a sensor for monitoring the sterilizing gas concentration within the headspace of the second vessel.
44 . The system of claim 23 , wherein the second vessel fluid outlet is in fluid communication with an apparatus for purifying and polishing a recombinant protein.
45 . The system of claim 23 , wherein the vessel is a sterilized vessel.Join the waitlist — get patent alerts
Track US2016115438A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.